Another anti-CD6 mAb has been used successfully in the treatment of psoriasis and thus far has an excellent safety record, pointing to the feasibility of testing anti-CD6 mAbs in the treatment of cancer as well as other autoimmune diseases (34, 35). Here, CD6 is linked to psoriasis.